The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.
Small medtech companies are finding value in outsourcing their research & development functions, according to a panel at a LifeScience Alley conference last week.
Starting a medtech company comes with a host of challenges, from regulation to financing to reimbursement. One way that companies can overcome those challenges, according to 2 industry experts, is to outsource some of the research and development work – and in the process, create a leaner, more flexible company.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: ConMed ripe for M&A spree; Baxter looks to growth post-Baxalta spinout; Sorin shareholders OK Cyberonics Merger